Primary Record
Succinyladenosine
- In stock
- 8,430 g
- Purity
- 98.6 %
- CAS
- 4542-23-8
Compound Identifiers & Properties
- CAS
- 4542-23-8
- PubChem CID
- 20849086
- SMILES
- C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N[C@@H](CC(=O)O)C(=O)O
- Canonical SMILES
- O=C(O)C[C@H](Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C(=O)O
Names & Synonyms
- Succinyladenosine
- Succinoadenosine
- N6-Succinyl Adenosine
- succinyl adenosine
- N6-Succinyloadenosine
- 4542-23-8
- RefChem:186376
- FZN9Z367G5
- CHEBI:71169
- DTXSID50196508
- C14H17N5O8
- orb1692417
- SCHEMBL23780815
- DTXCID20118999
- VKGZCEJTCKHMRL-MDBUBQOGSA-N
- (S)-N-(1,2-dicarboxyethyl)-Adenosine
- ZINC12494556
- AKOS040756152
- C14-H17-N5-O8
- NS16562
- (S)-N-(1,2-Dicarboxyethy l)adenosine
- CID:20849086
- MS-26287
- SID:163679241
- HY-113284
- J694.990H
- N-9-ribofuranosyl-9H-purin-6-yl-Aspartate
- N-9-ribofuranosyl-9H-purin-6-yl-Aspartic acid
- CS-0059510
- Adenosine, N-(1,2-dicarboxyethyl)-, (S)-
- G17498
- N-(9-beta-D-ribofuranosyl-9H-purin-6-yl)-L-aspartic acid
- 6-(1,2-Dicarboxyethylamino)-9-b-D-ribofuranosylpurine
- C043565
- N-(9-b-D-ribofuranosyl-9H-purin-6-yl)-L-Aspartic acid
- 6-(1,2-Dicarboxyethylamino)-9-beta-D-ribofuranosylpurine
- L-Aspartic acid, N-(9-beta-D-ribofuranosyl-9H-purin-6-yl)-
- N-(9-b-D-ribofuranosyl-9H-purin-6-yl)-L-Aspartate
- Q27139416
- (2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid
- N-(9-beta-delta-ribofuranosyl-9H-purin-6-yl)-L-Aspartate
- 6-(1,2-Dicarboxyethylamino)-9-beta-delta-ribofuranosylpurine
- N-(9-beta-delta-ribofuranosyl-9H-purin-6-yl)-L-Aspartic acid
- N-[9-(beta-D-Ribofuranosyl)-9H-purin-6-yl]-L-aspartic acid
- Aspartic acid, N-(9-beta-D-ribofuranosyl-9H-purin-6-yl)-, L-
- (2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic acid
- (2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl}amino)butanedioic acid
- (2S)-2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid
- (2S)-2-((9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-9H-purin-6-yl)amino)butanedioic acid
- (2S)-2-((9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)purin-6-yl)amino)butanedioic acid
- (2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-9H-purin-6-yl}amino)butanedioic acid
- (2S)-2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]butanedioic acid
- (9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)-L-aspartic acid